|
 |
|
|
|
|
79. R.X. Zhang et al., "Laboratory Studies of Berberine Used Alone and in Combination with 1,3-bis (2-chloroethyl) -l-nitrosourea to Treat Malignant Brain Tumors," Chinese Medical Journal (English)(8): 658-65 (1990). |
|
|
|
 |
|
|
|
|
80. R. Weiss, M.D., Herbal Medicine (Stuttgart, Germany: Hippokrates Verlag Publishers, 1985), 320-21. |
|
|
|
 |
|
|
|
|
81. H.C. Wood, M.D. et al., U.S. Dispensatory, 6th ed. (Washington, D.C.: H.C. Wood, 1883), 728-29. |
|
|
|
 |
|
|
|
|
82. K.C. Huang, The Pharmacology of Chinese Herbs (Boca Raton, Fla.: CRC Press, 1998), 155-56. |
|
|
|
 |
|
|
|
|
83. Y. Yamaoka, et al., "A Polysaccharide Fraction of Zizyphi Fructus in Augmenting Natural Killer Activity by Oral Administration," Biological and Pharmaceutical Bulletin 19 (7): 936-99 (1996). |
|
|
|
 |
|
|
|
|
84. E.M. McKelvey et al., "Dichloroallyl Lawsone," Clinical Pharmacology and Therapeutics 25 (5 Pt 1): 586-90 (1979). |
|
|
|
 |
|
|
|
|
85. D.B. Mowrey, Herbal Tonic Therapies (Los Angeles: Keats Publishing, 1993), 74-78. |
|
|
|
 |
|
|
|
|
86. S. Sinclair et al., "Chinese Herbs: A Clinical Review of Astragalus, Ligusticum and Schizandra," Alternative Medicine Review 3 (5): 338-44 (1998). |
|
|
|
 |
|
|
|
|
87. D.P. Reid, Chinese Herbal Medicine (Boston: Shambhala Publications, Inc., 1990), 553-54. |
|
|
|
 |
|
|
|
|
88. Ibid., 386-87. |
|
|
|
 |
|
|
|
|
89. S.K. Katiyar et al., "Protective Effects of Silymarin Against Photocarcinogenesis in a Mouse Skin Model," Journal of the National Cancer Institute 89 (9): 556-66 (1997). |
|
|
|
 |
|
|
|
|
90. J. Gaedeke et al., "Cisplatin Nephrotoxicity and Protection by Silibinin," Nephrology, Dialysis and Transplantation 11 (1): 55-62 (1996). |
|
|
|
 |
|
|
|
|
91. G. Scambia et al., "Antiproliferative Effect of Silybin on Gynaecological Malignancies: Synergism with Cisplatin and Doxorubicin," European Journal of Cancer 32A (5): 877-82 (1996). |
|
|
|
 |
|
|
|
|
92. X. Zi et al., "Anticarcinogenic Effect of a Flavonoid Antioxidant, Silymarin, in Human Breast Cancer Cells MDA-MB 468: Induction of G1 Arrest Through an Increase in Cip1/p21 Concomitant with a Decrease in Kinase Activity of Cyclin-Dependent Kinases and Associated Cyclins," Clinical Cancer Research 4 (4): 1055-64 (1998). |
|
|
|
 |
|
|
|
|
93. C.E. Elson et al., "Anti-carcinogenic Activity of D-limonene During the Initiation and Promotion/Progression Stages of DMBA-induced Rat Mammary Carcinogenesis," Carcinogenesis 9 (2): 331-32 (1988). |
|
|
|
|
|